{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:08:08Z","timestamp":1792634888204,"version":"4.5.0"},"reference-count":62,"publisher":"Bioscientifica","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA108646, CA098912"],"award-info":[{"award-number":["CA108646, CA098912"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>Radiotherapy is a mainstay treatment for localized prostate cancer (PCa). Yet, radiation resistance remains a major clinical obstacle. Here, radiation induced a BMP\/CD105-dependent metabolic shift in the tumor microenvironment that facilitates PCa cell survival. Using prostate tumor models and fibroblast cultures, we show that radiation enhances epithelial BMP ligand production, which promotes fibroblastic CD105 signaling. Metabolomic analysis upon radiation revealed that fibroblastic CD105 signaling elevated key enzymes involved in mitochondrial biogenesis (PGC1\u03b1) and ketogenesis (HMGCS2). The increased production of \u03b2-hydroxybutyrate in the tumor microenvironment sustained PCa cell energy metabolism and enhanced DNA repair upon radiation stress. Blocking BMP signaling through carotuximab (ENV105), a CD105-targeting antibody, disrupted epithelial\u2013fibroblast crosstalk, resulting in decreased \u03b2-hydroxybutyrate within the tumor microenvironment. This attenuation of fibroblast-mediated metabolic support increased DNA damage and apoptosis, sensitizing PCa cells to radiation. In subcutaneous mouse models, grafting PCa cells with CD105-KO or HMGCS2-KO fibroblasts yielded smaller tumors following radiation compared with wild-type fibroblast controls. Across subcutaneous and orthotopic models, combined treatment with carotuximab and irradiation reproducibly achieved superior tumor volume reduction relative to single-agent therapy. This study identified the BMP\/CD105 axis as a key pathway in radiation resistance, highlighting the potential of targeting fibroblastic CD105 with carotuximab to enhance radiation sensitivity.<\/jats:p>","DOI":"10.1530\/erc-25-0221","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:56:45Z","timestamp":1764082605000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":2,"title":["Radiation reprograms fibroblasts to drive prostate cancer therapy resistance"],"prefix":"10.1530","volume":"32","author":[{"given":"Anisha","family":"Madhav","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Thiruvalluvan","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Duong","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krizia","family":"Rohena-Rivera","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Mishra","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Billet","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Tripathi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Angara","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Stotland","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Andres","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta A","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"1"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S","family":"Zumsteg","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8747-5989","authenticated-orcid":true,"given":"Neil A","family":"Bhowmick","sequence":"additional","affiliation":[{"name":"1"},{"name":"4"},{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2026070909442643100_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026070909442643100_bib2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3390\/cancers14071688","article-title":"Adjuvant or salvage radiation therapy for prostate cancer after prostatectomy: current status, controversies and perspectives","volume":"14","author":"Terlizzi","year":"2022","journal-title":"Cancers"},{"key":"2026070909442643100_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2015.07.2284","article-title":"Radiation therapy intensification for solid tumors: a systematic review of randomized trials","volume":"93","author":"Yamoah","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026070909442643100_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","article-title":"Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026070909442643100_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"2026070909442643100_bib6","first-page":"S12","article-title":"Treatment options after failure of radiation therapy-a review","volume":"4","author":"Rukstalis","year":"2002","journal-title":"Rev Urol"},{"key":"2026070909442643100_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.urolonc.2016.06.002","article-title":"What is the best way to radiate the prostate in 2016?","volume":"35","author":"Moon","year":"2017","journal-title":"Urol Oncol"},{"key":"2026070909442643100_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"key":"2026070909442643100_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/stem.318","article-title":"Radiation resistance of cancer stem cells: the 4 R\u2019s of radiobiology revisited","volume":"28","author":"Pajonk","year":"2010","journal-title":"Stem Cells"},{"key":"2026070909442643100_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol Cancer"},{"key":"2026070909442643100_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1078-0432.CCR-24-2483","article-title":"Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer","volume":"31","author":"Stopsack","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026070909442643100_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070909442643100_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"2026070909442643100_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-\u00df signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"key":"2026070909442643100_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat Cell Biol"},{"key":"2026070909442643100_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib17","first-page":"8135","article-title":"Malignant transformation in a nontumorigenic human prostatic epithelial cell line","volume":"61","author":"Hayward","year":"2001","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2017.02.019","article-title":"Cancer-associated fibroblasts promote irradiated cancer cell recovery through autophagy","volume":"17","author":"Wang","year":"2017","journal-title":"EBioMedicine"},{"key":"2026070909442643100_bib19","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol"},{"key":"2026070909442643100_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI30740","article-title":"Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression","volume":"117","author":"Biswas","year":"2007","journal-title":"J Clin Investig"},{"key":"2026070909442643100_bib21","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1158\/0008-5472.CAN-11-1212","article-title":"Blockade of TGF-\u03b2 signaling by the TGF\u03b2R-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib22","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1038\/s41388-018-0278-0","article-title":"Antagonizing CD105 enhances radiation sensitivity in prostate cancer","volume":"37","author":"Madhav","year":"2018","journal-title":"Oncogene"},{"key":"2026070909442643100_bib23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","article-title":"Transcriptional control by the TGF-beta\/Smad signaling system","volume":"19","author":"Massague","year":"2000","journal-title":"EMBO J"},{"key":"2026070909442643100_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1074\/jbc.274.2.584","article-title":"Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily","volume":"274","author":"Barbara","year":"1999","journal-title":"J Biol Chem"},{"key":"2026070909442643100_bib25","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1074\/jbc.M611062200","article-title":"Endoglin differentially modulates antagonistic transforming growth factor-\u03b21 and BMP-7 signaling","volume":"282","author":"Scherner","year":"2007","journal-title":"J Biol Chem"},{"key":"2026070909442643100_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-19-0370","article-title":"Soluble CD105 is prognostic of disease recurrence in prostate cancer patients","volume":"27","author":"Placencio-Hickok","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"2026070909442643100_bib27","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40170-017-0166-z","article-title":"The action of beta-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a beta-hydroxybutyrate paradox","volume":"5","author":"Rodrigues","year":"2017","journal-title":"Cancer Metab"},{"key":"2026070909442643100_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"2026070909442643100_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/bjc.2013.21","article-title":"Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair","volume":"108","author":"Groselj","year":"2013","journal-title":"Br J Cancer"},{"key":"2026070909442643100_bib31","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070909442643100_bib32","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1172\/JCI99397","article-title":"Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming","volume":"128","author":"Mishra","year":"2018","journal-title":"J Clin Investig"},{"key":"2026070909442643100_bib33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41388-018-0461-3","article-title":"Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner","volume":"38","author":"Kato","year":"2019","journal-title":"Oncogene"},{"key":"2026070909442643100_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1667\/RR13583.1","article-title":"Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells","volume":"181","author":"Chu","year":"2014","journal-title":"Radiat Res"},{"key":"2026070909442643100_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050920","article-title":"Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies","volume":"7","author":"Nolan-Stevaux","year":"2012","journal-title":"PLoS One"},{"key":"2026070909442643100_bib36","first-page":"1851","article-title":"Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells","volume":"25","author":"Warrington","year":"2005","journal-title":"Anticancer Res"},{"key":"2026070909442643100_bib37","first-page":"2283","article-title":"Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy","volume":"31","author":"Nassiri","year":"2011","journal-title":"Anticancer Res"},{"key":"2026070909442643100_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","article-title":"Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2026070909442643100_bib39","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1541-7786.MCR-18-0321","article-title":"Radiation-induced myofibroblasts promote tumor growth via mitochondrial ROS\u2013activated TGF\u03b2 signaling","volume":"16","author":"Shimura","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2026070909442643100_bib40","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1074\/jbc.M113.530527","article-title":"A novel MitoTimer reporter gene for mitochondrial content, structure, stress, and damage in vivo","volume":"289","author":"Laker","year":"2014","journal-title":"J Biol Chem"},{"key":"2026070909442643100_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00109-014-1230-6","article-title":"MitoTimer: a novel protein for monitoring mitochondrial turnover in the heart","volume":"93","author":"Gottlieb","year":"2015","journal-title":"J Mol Med"},{"key":"2026070909442643100_bib42","first-page":"63","article-title":"Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: unique presenting laboratory values and a review of biochemical and clinical features","volume":"40","author":"Conboy","year":"2018","journal-title":"JIMD Rep"},{"key":"2026070909442643100_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066855","article-title":"Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy","volume":"8","author":"Erho","year":"2013","journal-title":"PLoS One"},{"key":"2026070909442643100_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-Hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"2026070909442643100_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fnmol.2016.00122","article-title":"Tumor metabolism, the ketogenic diet and beta-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy","volume":"9","author":"Woolf","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"2026070909442643100_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-018-0180-9","article-title":"Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation","volume":"6","author":"Bartmann","year":"2018","journal-title":"Cancer Metab"},{"key":"2026070909442643100_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177840","article-title":"Targeting ketone body metabolism in mitigating gemcitabine resistance","volume":"9","author":"Rohena-Rivera","year":"2024","journal-title":"JCI Insight"},{"key":"2026070909442643100_bib48","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cellsig.2016.04.005","article-title":"beta-Hydroxybutyrate: a signaling metabolite in starvation response?","volume":"28","author":"Rojas-Morales","year":"2016","journal-title":"Cell Signal"},{"key":"2026070909442643100_bib49","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G","volume":"280","author":"Taggart","year":"2005","journal-title":"J Biol Chem"},{"key":"2026070909442643100_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-022-04649-6","article-title":"\u03b2-Hydroxybutyrate suppresses colorectal cancer","volume":"605","author":"Dmitrieva-Posocco","year":"2022","journal-title":"Nature"},{"key":"2026070909442643100_bib51","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.4161\/cc.22136","article-title":"Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells","volume":"11","author":"Martinez-Outschoorn","year":"2012","journal-title":"Cell Cycle"},{"key":"2026070909442643100_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2016.02.003","article-title":"Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy","volume":"112","author":"Gong","year":"2016","journal-title":"Eur J Med Chem"},{"key":"2026070909442643100_bib53","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/jm800079s","article-title":"A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo","volume":"51","author":"Jones","year":"2008","journal-title":"J Med Chem"},{"key":"2026070909442643100_bib54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4161\/cbt.12.6.15956","article-title":"The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells","volume":"12","author":"Wilson","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"2026070909442643100_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"key":"2026070909442643100_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fnmol.2017.00377","article-title":"Ketone-based metabolic therapy: is increased NAD(+) a primary mechanism?","volume":"10","author":"Elamin","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"2026070909442643100_bib57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bju.12986","article-title":"A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer","volume":"116","author":"Karzai","year":"2015","journal-title":"BJU Int"},{"key":"2026070909442643100_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res"},{"key":"2026070909442643100_bib59","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1038\/onc.2008.293","article-title":"Prostate tumor progression is mediated by a paracrine TGF-\u03b2\/Wnt3a signaling axis","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"2026070909442643100_bib60","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1158\/0008-5472.CAN-07-6289","article-title":"Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity","volume":"68","author":"Placencio","year":"2008","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib61","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"2026070909442643100_bib62","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1038\/onc.2013.431","article-title":"A reciprocal role of prostate cancer on stromal DNA damage","volume":"33","author":"Banerjee","year":"2014","journal-title":"Oncogene"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/12\/ERC-25-0221.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/12\/ERC-25-0221.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0221\/506148\/erc-25-0221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0221\/506148\/erc-25-0221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:44:39Z","timestamp":1783604679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/12\/e250221\/75522\/Radiation-reprograms-fibroblasts-to-drive-prostate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0221","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"e250221"}}